Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy

Korosec P.; Ziberna K.; Silar M.; Dezman M.; Smodis N. Celesnik; Rijavec M.; Kopac P.; Erzen R.; Lalek N.; Bajrovic N.; Kosnik M.; Zidarn M.

首页> 外文期刊>Clinical and experimental allergy : >Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy

【24h】

Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy

机译：蜜蜂毒液免疫治疗建立阶段与不良全身反应相关的免疫学和临床因素

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background Adverse systemic reactions (SRs) are more common in honeybee venom immunotherapy (VIT) than in wasp VIT. Factors that might be associated with SRs during the honeybee VIT are poorly understood.

机译：背景技术蜜蜂毒液免疫治疗（VIT）中的全身不良反应（SRs）比黄蜂VIT更常见。对蜜蜂VIT期间与SR相关的因素了解甚少。

著录项

来源
《Clinical and experimental allergy :》 |2015年第10期|共11页
作者
Korosec P.; Ziberna K.; Silar M.; Dezman M.; Smodis N. Celesnik; Rijavec M.; Kopac P.; Erzen R.; Lalek N.; Bajrovic N.; Kosnik M.; Zidarn M.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词
adverse systemic reactions; basophils; CD63; honeybee venom allergy; IgE; immunotherapy; risk factors;

机译：不良全身反应;嗜碱性粒细胞;CD63;蜜蜂毒液过敏;IgE;免疫治疗;危险因素;

相似文献

外文文献
中文文献
专利

1. Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy [J] . Korosec P., Ziberna K., Silar M., Clinical and experimental allergy : . 2015,第10期

机译：蜜蜂毒液免疫治疗建立阶段与不良全身反应相关的免疫学和临床因素
2. Risk factors for severe systemic sting reactions in wasp ( Vespula spp.) and honeybee ( Apis mellifera ) venom allergic patients [J] . Danielle Fehr, Sara Micaletto, Thomas Moehr, Clinical and Translational Allergy . 2019,第1期

机译：黄蜂（Vespula spp。）和蜜蜂（Apis mellifera）毒液过敏患者中严重全身性刺痛反应的危险因素。
3. Absence of systemic immunologic changes during dose build-up phase and early maintenance period in effective specific sublingual immunotherapy in children. [J] . Dehlink E, Eiwegger T, Gerstmayr M, Clinical and experimental allergy : . 2006,第1期

机译：在儿童有效的特殊舌下免疫治疗中，在剂量累积阶段和维持早期阶段没有全身免疫学改变。
4. Anti-IgE Treatment Overcomes Intolerability of Honeybee- Venom Ultra-Rush Immunotherapy in Indolent Systemic Mastocytosis [C] . B. Wedi, D. Wieczorek, U. Raap, Collegium Internationale Allergologicum . 2007

机译：抗IgE治疗克服了蜜腺超鼠疫免疫疗法在惰性全身乳细胞诱变中的不耐受性
5. CHARACTERIZATIONS AND IMMUNOTHERAPY OF FELINE RETROVIRAL (FELV) ASSOCIATED HEMATOPOIETIC MALIGNANCIES AND IMMUNODEFICIENCY: CLINICAL, IMMUNOLOGICAL AND PATHOLOGICAL STUDIES. [D] . ENGELMAN, ROBERT WILLIAM. 1985

机译：猫反转录（FELV）相关性造血疾病和免疫缺陷的特征和免疫治疗：临床，免疫学和病理学研究。
6. Risk factors for severe systemic sting reactions in wasp (Vespula spp.) and honeybee (Apis mellifera) venom allergic patients [O] . Danielle Fehr, Sara Micaletto, Thomas Moehr, 2019

机译：黄蜂（Vespula spp。）和蜜蜂（Apis mellifera）毒液过敏患者中严重全身性刺痛反应的危险因素
7. β‐blockers and ACE inhibitors are not a risk factor for severe systemic sting reactions and adverse events during venom immunotherapy [O] . Gunter Johannes Sturm, Sereina Annik Herzog, Werner Aberer, 2021

机译：β-嵌障人员和ACE抑制剂不是毒液免疫疗法严重全身刺痛反应和不良事件的危险因素

Immunological and clinical factors associated with adverse systemic reactions during the build-up phase of honeybee venom immunotherapy

摘要

著录项

相似文献

相关主题

期刊订阅